// App-Quantinova.ai

4091 : JAK Inhibitors Are Not Associated With a Reduction In Novel Markers Of Thrombosis In Myeloproliferative Neoplasms

Researchers

Presenter

  • Clodagh Keohane

Principal Investigators

  • Sophia Katiri

  • Christopher Connor

  • Katy Sanchez

  • Roxanne Godfrey

  • Deepti H Radia

  • Donal McLornan

  • Claire N Harrison

Medical Centers

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Polycythaemia vera

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • Monocyte

  • Cluster of Differentiation 14

  • Coagulation Factor III, Tissue Factor

  • Janus kinase

Drug/Treatment

  • Hydroxycarbamide

  • Ruxolitinib phosphate

  • Interferon

  • Fedratinib

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved